CMBA organized experts to communicate with American Celgene Corporation
2014-09-16
On September 14th 2012, Mr. Rajesh, vice president of the Global Transformation and Early Drug Development Department of Celgene Corporation in America, visited CMBA in Beijing. CMBA was asked to organize experts from the Professional Committee of Clinical Application of CMBA to change views with visitors. Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of therapies designed to treat cancers and blood related diseases. During the visit, Celgene Corporation introduced a variety of drugs that have been approved listed or in clinical trials and had a heated discussion with CMBA experts on problems that both sides currently encountered during the treatment of cancers and blood related diseases. Both sides look forward to the further cooperation in the future. Professor Ren Xiubao from Tianjin Cancer Hospital, Professor Tong Chunrong from Beijing Daopei Hospital, general manager Wu Haibo from Beijing Giant Med-Pharma Services, Inc., Secretary-general Wu Zhaohui and Zhangwen from CMBA participated the discussion.
